Determinants of long-term response to patritumab deruxtecan (HER3-DXd) in breast cancer patient-derived xenografts.
RNA-seq (gene expression) · human · 167 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 167 samples: 158 distinct titles, 9 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenograftsNPJ precision oncology · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE310423_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1365916 and SRA study SRP618728. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 167 sample titles: 158 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9227031 PDX127_1027_20_CNTL_4L
- GSM9227032 PDX127_1156_21_U3_3_31L
- GSM9227033 PDX127_1085_20_U3_3_21L
- GSM9227034 PDX313_1149_21_CNTL_4R
- GSM9227035 PDX313_1149_21_U3_3_31L
- GSM9227036 PDX313_1068_20_U3_3_21L
- GSM9227037 PDX044_1269_21_CNTL_2L
- GSM9227038 PDX044_1269_21_U3_3_22R
- GSM9227039 PDX044_1060_20_U3_3_32R
- GSM9227040 PDX060_1347_22_CNTL_2R
- GSM9227041 PDX060_1347_22_U3_3_21R
- GSM9227042 PDX060_1059_22_U3_3_21L
- GSM9227043 PDX098_1260_21_CNTL_3L
- GSM9227044 PDX098_1260_21_U3_3_22L
- GSM9227045 PDX098_1061_20_U3_3_31L
- GSM9227046 PDX288_1361_22_CNTL_2R
- GSM9227047 PDX288_1361_22_U3_3_21L
- GSM9227048 PDX288_1069_20_U3_3_22L
- GSM9227049 PDX457_1092_20_CNTL_3R
- GSM9227050 PDX457_1223_21_U3_3_32L
- GSM9227051 PDX457_1092_20_U3_3_22R
- GSM9227052 PDX474.7_1251_21_CNTL_2R
- GSM9227053 PDX474.7_1251_21_U3_3_22L
- GSM9227054 PDX474.7_1252_21_U3_3_22R
- GSM9227055 PDX179_1401_23_CNTL_3R
- GSM9227056 PDX179_1401_23_U3_3_21L
- GSM9227057 PDX179_1323_22_U3_3_21L
- GSM9227058 PDX341_1476_24_CNTL_1R
- GSM9227059 PDX341_1476_24_U3_3_11L
- GSM9227060 PDX341_1481_24_U3_3_11L
- GSM9227061 PDX404_1195_21_CNTL_1L
- GSM9227062 PDX131_passage_19_5767
- GSM9227063 PDX476.2_passage_5_5423
- GSM9227064 PDX346_1187_21_CNTL_1R
- GSM9227065 PDX533_1205_21_CNTL_2L
- GSM9227066 PDX490_1181_21_CNTL_2L
- GSM9227067 PDX479_1078_20_CNTL_62R
- GSM9227068 PDX456.2_1157_21_CNTL_2L
- GSM9227069 PDX039_1176_21_CNTL_1R
- GSM9227070 PDX350.2_1038_20_CNTL_1R
+ 127 more — browse all 167 samples with per-sample file links →
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE207924 Genome-wide quantification of RNA flow across subcellular compartments reveals determinants of the transcript life cycle [RNA-seq] 160 samples shares determinants
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.